STN vs. GPi Deep Brain Stimulation: Translating the Rematch into Clinical Practice

Area of Science:

• Neurosurgery
• Neurology
• Biomedical Engineering

Background:

• Deep brain stimulation (DBS) is a key treatment for Parkinson's disease (PD).
• Historically, bilateral subthalamic nucleus (STN) DBS was standard practice.
• Recent evidence questions the universal applicability of this approach.

Purpose of the Study:

• To review evidence comparing STN vs. globus pallidus internus (GPi) DBS targets.
• To evaluate unilateral vs. bilateral DBS approaches for PD.
• To propose a patient-tailored treatment strategy for PD DBS.

Main Methods:

• Systematic review of clinical trials and follow-up studies.
• Analysis of outcomes for STN vs. GPi targets.
• Comparison of unilateral vs. bilateral stimulation efficacy.

Main Results:

• Both STN and GPi targets improve motor symptoms and tremor.
• STN DBS offers greater medication reduction and cost-effectiveness.
• GPi DBS provides superior dyskinesia control and programming flexibility, especially for unilateral cases.

Conclusions:

• A one-size-fits-all bilateral STN DBS approach is suboptimal for all PD patients.
• Patient-tailored, symptom-specific DBS strategies are recommended.
• Interdisciplinary teams are crucial for optimizing PD DBS treatment planning and risk-benefit analysis.